A carregar...
Drug target ranking for glioblastoma multiforme
BACKGROUND: Glioblastoma Multiforme, an aggressive primary brain tumor, has a poor prognosis and no effective standard of care treatments. Most patients undergoing radiotherapy, along with Temozolomide chemotherapy, develop resistance to the drug, and recurrence of the tumor is a common issue after...
Na minha lista:
| Publicado no: | BMC Biomed Eng |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8074458/ https://ncbi.nlm.nih.gov/pubmed/33902757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42490-021-00052-w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|